Literature DB >> 19214284

The potential impact of contemporary developments in the management of patients with gastroesophageal reflux disease undergoing an initial gastroscopy.

Suhail B Salem1, Yael Kushner, Victoria Marcus, Serge Mayrand, Carlos A Fallone, Alan N Barkun.   

Abstract

BACKGROUND: Recent developments may alter the approach to patients presenting with gastroesophageal reflux disease (GERD)-like symptoms. A newly proposed Montreal consensus definition of Barrett's esophagus includes all types of esophageal columnar metaplasia, with or without intestinal-type metaplasia. There is also increasing recognition of eosinophilic esophagitis (EE) in patients with GERD-like symptoms.
OBJECTIVE: To quantify the impact of these developments on a multiphysician general gastroenterology practice in a tertiary care medical centre.
METHODS: Medical charts of all patients having an initial gastroscopy for GERD-like symptoms over a one-year period were reviewed retrospectively, and audits of their endoscopic images and esophageal biopsies were performed.
RESULTS: Of the 353 study participants, typical symptoms of heartburn and acid reflux were present in 87.7% and 23.2%, respectively. Less commonly, patients presented with atypical symptoms (eg, dysphagia in 9.4%). At endoscopy, 26% were found to have erosive esophagitis and 12% had endoscopically suspected esophageal metaplasia. Histological evaluation was available for 65 patients. Ten of the 65 biopsied patients (15%) met traditional criteria for Barrett's esophagus (ie, exhibiting intestinal-type metaplasia), whereas 49 (75%) fulfilled the newly proposed consensus definition of Barrett's esophagus. Five patients (7.7%) met the study criteria for EE (more than 20 eosinophils per high-power field), four of whom had not been previously recognized.
CONCLUSIONS: Among patients presenting with GERD-like symptoms, the prevalence of Barrett's esophagus may increase markedly if the Montreal definition is adopted. In addition, growing awareness of EE may lead to an increase in the prevalence of this diagnosis. Prospective studies of the management implications of these findings are warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19214284      PMCID: PMC2694588          DOI: 10.1155/2009/859271

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  21 in total

1.  Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

Authors:  Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

2.  The endoscopic assessment of esophagitis: a progress report on observer agreement.

Authors:  D Armstrong; J R Bennett; A L Blum; J Dent; F T De Dombal; J P Galmiche; L Lundell; M Margulies; J E Richter; S J Spechler; G N Tytgat; L Wallin
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

3.  Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.

Authors:  Rebecca Harrison; Ian Perry; William Haddadin; Stuart McDonald; Richard Bryan; Keith Abrams; Richard Sampliner; Nicholas J Talley; Paul Moayyedi; Janusz A Jankowski
Journal:  Am J Gastroenterol       Date:  2007-04-13       Impact factor: 10.864

4.  Vertical lines in distal esophageal mucosa (VLEM): a true endoscopic manifestation of esophagitis in children?

Authors:  S K Gupta; J F Fitzgerald; S K Chong; J M Croffie; M H Collins
Journal:  Gastrointest Endosc       Date:  1997-06       Impact factor: 9.427

Review 5.  The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett.

Authors:  S J Spechler; R K Goyal
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

6.  Definition of histopathologic changes in gastroesophageal reflux disease.

Authors:  P T Chandrasoma; D M Lokuhetty; T R Demeester; C G Bremmer; J H Peters; S Oberg; S Groshen
Journal:  Am J Surg Pathol       Date:  2000-03       Impact factor: 6.394

Review 7.  Eosinophilic esophagitis in children and adults.

Authors:  Chris A Liacouras
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003 Nov-Dec       Impact factor: 2.839

Review 8.  Barrett's esophagus: histopathologic definitions and diagnostic criteria.

Authors:  James Mueller; Martin Werner; Manfred Stolte
Journal:  World J Surg       Date:  2004-01-20       Impact factor: 3.352

9.  The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?

Authors:  A Meining; R Ott; I Becker; S Hahn; J Mühlen; M Werner; H Höfler; M Classen; W Heldwein; T Rösch
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

10.  Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment.

Authors:  Nimish B Vakil; Barry Traxler; Douglas Levine
Journal:  Clin Gastroenterol Hepatol       Date:  2004-08       Impact factor: 11.382

View more
  2 in total

1.  Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis.

Authors:  Katie S Nason; Promporn Paula Wichienkuer; Omar Awais; Matthew J Schuchert; James D Luketich; Robert W O'Rourke; John G Hunter; Cynthia D Morris; Blair A Jobe
Journal:  Arch Surg       Date:  2011-07

2.  British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults.

Authors:  Anjan Dhar; Hasan N Haboubi; Stephen E Attwood; Marcus K H Auth; Jason M Dunn; Rami Sweis; Danielle Morris; Jenny Epstein; Marco R Novelli; Hannah Hunter; Amanda Cordell; Sharon Hall; Jamal O Hayat; Kapil Kapur; Andrew Robert Moore; Carol Read; Sarmed S Sami; Paul J Turner; Nigel J Trudgill
Journal:  Gut       Date:  2022-05-23       Impact factor: 31.793

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.